home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9408c.zip
/
M9480652.TXT
< prev
next >
Wrap
Text File
|
1994-08-20
|
2KB
|
28 lines
Document 0652
DOCN M9480652
TI [Opportunistic infections in AIDS: the benefits of an umbrella strategy.
From an interview with Professor Willy Rozenbaum]
DT 9410
AU Rozenbaum W; Service des Maladies Infectieuses, Hopital Rothschild,
Pris.
SO Allerg Immunol (Paris). 1994 Apr;26(4):153-5. Unique Identifier :
AIDSLINE MED/94304499
AB Availability to practitioners of a treatment for infections by atypical
mycobacteria by Ansatipine should produce a reduction or delay in the
frequency of opportunistic infections in AIDS, which are a heavy burden
on the future of the patients and seriously after their quality of life.
Today, the practice of prescribing Ansatipine increase the prophylactic
strategy for opportunistic infections in AIDS, or the Umbrella strategy.
This can only improve the possible therapies for practitioners who are
faced with the complexity of the disease and bring real benefit to the
patients. Distribution of Ansatipine to town pharmacies is a new step in
this direction.
DE AIDS-Related Opportunistic Infections/MICROBIOLOGY/*PREVENTION &
CONTROL/PARASITOLOGY English Abstract Human Pharmacies Quality of
Life Rifabutin/SUPPLY & DISTRIBUTION/*THERAPEUTIC USE INTERVIEW
JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).